These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 7752584)

  • 1. Urinary neutral endopeptidase 24.11 activity: modulation by chronic salt loading.
    Aviv R; Gurbanov K; Hoffman A; Blumberg S; Winaver J
    Kidney Int; 1995 Mar; 47(3):855-60. PubMed ID: 7752584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. pH- and time-dependent inhibition of rat kidney neutral endoprotease 24.11 by thiorphan and phosphoramidon.
    Jeng AY; Ansell J; Erion MD
    Life Sci; 1989; 45(22):2109-14. PubMed ID: 2601566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of neutral endopeptidase potentiates the effects of atrial natriuretic peptide on acute cyclosporin-induced nephrotoxicity.
    Capasso G; Unwin R; Ciani F; Rizzo A; Russo F; Pica A; De Santo NG
    Nephron; 2000 Nov; 86(3):298-305. PubMed ID: 11096287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of converting enzyme inhibitor and neutral endopeptidase inhibitor on blood pressure and renal function in experimental hypertension.
    Pham I; Gonzalez W; el Amrani AI; Fournié-Zaluski MC; Philippe M; Laboulandine I; Roques BP; Michel JB
    J Pharmacol Exp Ther; 1993 Jun; 265(3):1339-47. PubMed ID: 8389863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Localization and characterization of neutral metalloendopeptidase (EC 3.4.24.11), the degradative enzyme for atrial natriuretic peptide, in rat kidney using a radioiodinated neutral metalloendopeptidase inhibitor.
    Kanazawa M; Casley DJ; Sybertz EJ; Haslanger MF; Johnston CI
    J Pharmacol Exp Ther; 1992 Jun; 261(3):1231-7. PubMed ID: 1534841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of neutral endopeptidase 24.11 in dog glomeruli.
    Landry C; Santagata P; Bawab W; Fournié-Zaluski MC; Roques BP; Vinay P; Crine P
    Biochem J; 1993 May; 291 ( Pt 3)(Pt 3):773-9. PubMed ID: 8489505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purification and characterization of a neutral endopeptidase-like enzyme from human urine.
    Di Marco GS; Quinto BM; Juliano M; Carmona AK; Stella RC; Plavnik FL; Casarini DE
    J Hypertens; 1998 Dec; 16(12 Pt 2):1971-8. PubMed ID: 9886885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of the selective neutral endopeptidase inhibitor, retrothiorphan, on renal function and blood pressure in conscious normotensive Wistar and hypertensive DOCA-salt rats.
    Pham I; el Amrani AI; Fournié-Zaluski MC; Corvol P; Roques B; Michel JB
    J Cardiovasc Pharmacol; 1992 Dec; 20(6):847-57. PubMed ID: 1282584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterisation of neutral endopeptidase 3.4.24.11 (NEP) in the kidney: comparison between normotensive, genetically hypertensive and experimentally hypertensive rats.
    Schulz R; Sakane Y; Berry C; Ghai R
    J Enzyme Inhib; 1991; 4(4):347-58. PubMed ID: 1669834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutagenesis of Glu403 to Cys in rabbit neutral endopeptidase-24.11 (neprilysin) creates a disulphide-linked homodimer: analogy with endothelin-converting enzyme.
    Hoang MV; Sansom CE; Turner AJ
    Biochem J; 1997 Nov; 327 ( Pt 3)(Pt 3):925-9. PubMed ID: 9581575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms underlying the augmented responses of deoxycorticosterone acetate-salt hypertensive rats to neutral endopeptidase inhibitors.
    Hirata Y; Suzuki Y; Suzuki E; Hayakawa H; Kimura K; Goto A; Omata M; Minamino N; Kangawa K; Matsuo H
    J Hypertens; 1994 Apr; 12(4):367-74. PubMed ID: 8064160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular A10 cell membranes contain an endothelin metabolizing neutral endopeptidase.
    Dickinson KE; Tymiak AA; Cohen RB; Liu EC; Webb ML; Hedberg A
    Biochem Biophys Res Commun; 1991 Apr; 176(1):423-30. PubMed ID: 2018530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of neutral endopeptidase 24.11 in AV fistular rat model of heart failure.
    Wegner M; Hirth-Dietrich C; Stasch JP
    Cardiovasc Res; 1996 Jun; 31(6):891-8. PubMed ID: 8759244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble recombinant neprilysin induces aggrecanase-mediated cleavage of aggrecan in cartilage explant cultures.
    Chevrier A; Mort JS; Crine P; Hoemann CD; Buschmann MD
    Arch Biochem Biophys; 2001 Dec; 396(2):178-86. PubMed ID: 11747295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the neutral endopeptidase inhibitor thiorphan on cardiovascular and renal function in cirrhotic rats.
    Park KS; Li Y; Zhang Y; Gerbes AL; Liu H; Swain MG; Lee SS
    Br J Pharmacol; 2003 May; 139(1):81-8. PubMed ID: 12746226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neprilysin degrades both amyloid beta peptides 1-40 and 1-42 most rapidly and efficiently among thiorphan- and phosphoramidon-sensitive endopeptidases.
    Shirotani K; Tsubuki S; Iwata N; Takaki Y; Harigaya W; Maruyama K; Kiryu-Seo S; Kiyama H; Iwata H; Tomita T; Iwatsubo T; Saido TC
    J Biol Chem; 2001 Jun; 276(24):21895-901. PubMed ID: 11278416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of a neutral endopeptidase inhibitor, BP102, on the development of deoxycorticosterone acetate-salt hypertension in kininogen-deficient Brown Norway Katholiek rats.
    Nakajima S; Majima M; Ito H; Hayashi I; Yajima Y; Katori M
    Int J Tissue React; 1998; 20(2):45-56. PubMed ID: 9638501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the cardiovascular and neural activity of endothelin-1, -2, -3 and respective proendothelins: effects of phosphoramidon and thiorphan.
    Mattera GG; Eglezos A; Renzetti AR; Mizrahi J
    Br J Pharmacol; 1993 Sep; 110(1):331-7. PubMed ID: 8106108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Degradation of atrial natriuretic peptide: pharmacologic effects of protease EC 24.11 inhibition.
    Webb RL; Yasay GD; McMartin C; McNeal RB; Zimmerman MB
    J Cardiovasc Pharmacol; 1989 Aug; 14(2):285-93. PubMed ID: 2476603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enkephalinase inhibition increases plasma atrial natriuretic peptide levels, glomerular filtration rate, and urinary sodium excretion in rats with reduced renal mass.
    Lafferty HM; Gunning M; Silva P; Zimmerman MB; Brenner BM; Anderson S
    Circ Res; 1989 Sep; 65(3):640-6. PubMed ID: 2548762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.